Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 46.77 K168.3 K246.91 K288.57 K 750.55 K Research & development ———— — Operating income -46.77 K-168.3 K-246.91 K-288.57 K -750.55 K Non-Operating Income, Total 01.16 M2.45 M1.96 M 5.57 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses 01.16 M2.45 M1.96 M 5.57 M Unusual income/expense ———— — Pretax income -46.77 K988.17 K2.21 M1.67 M 4.82 M Equity in earnings ———— — Taxes ———— — Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -46.77 K988.17 K2.21 M1.67 M 4.82 M Discontinued operations ———— — Net income -46.77 K988.17 K2.21 M1.67 M 4.82 M Dilution adjustment —231.31 M—235.57 M — Preferred dividends —231.31 M—235.57 M — Diluted net income available to common stockholders -46.77 K988.17 K2.21 M1.67 M 4.82 M Basic earnings per share (Basic EPS) -0.010.120.180.12 0.41 Diluted earnings per share (Diluted EPS) -0.010.10.180.12 0.39 Average basic shares outstanding 5 M12.02 M18.19 M29.41 M — Diluted shares outstanding 5 M12.21 M18.32 M29.41 M — EBITDA ———— — EBIT ———— — Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) ———— —